ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ORMP vs SION // ENTERPRISE SCALE & MARKET CAP

Oramed Pharmaceuticals Inc. (NASDAQ) VS. Sionna Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ORMP 3 — SION 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: SION
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORMP VS. SION) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ORMP SION SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 0.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -7.80% -28.30% +20.50 ORMP /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.20% — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin 3.80% — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 ORMP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.6 33.5 +7.10 ORMP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $171.0M $175.0M -$4.0M SION /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ORMP REV SION REV ORMP GROSS % SION GROSS % ORMP FCF SION FCF
FY 2025 $2.0M $249.1M 0.7% — -$9.2M -$66.7M
FY 2024 $35.8M $197.6M — — -$8.4M -$52.8M
FY 2023 $1.3M — — — -$10.3M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORMP // BETA —
SION // BETA —